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DEAN’S RESEARCH NEWSLETTER

Summer 2019

Welcome students, faculty, staff, colleagues and fellow researchers.
Research is one of the major missions of the School of Medicine (SOM). As
dean of the School of Medicine, I am pleased that we have some very
exciting on-going research advances at NYMC and with our affiliated
hospital partners. My newsletters will provide a sample of these activities
and up to date information related to research. I’m excited to announce a
new initiative in which I will be partnering with Salomon Amar, D.D.S.,
Ph.D., vice president for research, and Marina K. Holz, Ph.D., dean,
Graduate School of Basic Medical Sciences, to develop a new research
incentive plan for our faculty. Stay tuned as we will update you soon! I
hope you will find the news of awards and accolades as useful and
motivating as I do. Kudos to everyone as you continue your success with
research, collaborations and grants. I look forward to hearing from you as
I present these newsletters on behalf of NYMC SOM. I encourage you to
continue to follow helpful updates from Dr. Amar and the Office of Research Administration (ORA).
Great things are happening here!

Jerry L. Nadler, M.D., MACP, FAHA, FACE
Dean of the School of Medicine
Professor of Medicine and Pharmacology

00

v

Recommended article in the current issue of
Advancing Care in the Hudson Valley, a publication of
Westchester Medical Center.
Click below to read:
Advancing Care in the Hudson Valley
Mitchell S. Cairo, M.D., professor of pediatrics,
Division of Pediatric Hematology, Oncology and
Stem Cell Transplantation, professor of medicine,
pathology, microbiology and immunology,
cell biology and anatomy, “Building Better Cells.”
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AFFILIATE HOSPITALS RESEARCH ACTIVITY
METROPOLITAN RESIDENT RESEARCH DAY
The Annual Resident Research Day of New York Medical College at
NYC Health + Hospitals/Metropolitan was held on April 4, 2019. All
clinical departments participated and presented highlights of the investigative
work that NYMC medical and dental residents perform under faculty
mentorship in the hospital’s clinics, inpatient units, emergency and operating
rooms. The judges included John Pellicone, M.D., associate dean for
medical eduation, NYMC, chief medical officer Metropolitan Hospital, and
Jerry Nadler, M.D., M.A.C.P., F.A.H.A., F.A.C.E., dean of the School of
Medicine. Dr. Nadler presented the awards to the following residents:
First Place: Jared Theriot, M.D., PGY2 resident in the NYMC surgery program (center) "The Benefits of a
Muscle-Sparing Below Knee Amputation in the Elderly Population"
Second Place: Carissa Dumancas, M.D., PGY3 resident, NYMC internal medicine program (left) "Clinical
Utility of an Observation Unit in the Outcome of Cocaine-Induced Chest Pain"
Third Place: Rene Eapen, M.D., PGY3 resident in the NYMC internal medicine program (right) "Medical
Optimization Team (MOT), A Patient Care Improvement Project - Model of Care"

ON-GOING RESEARCH AT NYC + HOSPITALS/METROPOLITAN
Joseph Morales, D.D.S., chair of the Department of Dental
Medicine, NYMC SOM, is the primary investigator in collaboration
with Zvi Loewy, Ph.D., adjunct professor microbiology and
immunology, of the study, “Oral Microbiome: Relationship of
Stomatitis of Denture Wearers and Chronic Obstructive Pulmonary
Disease.” Clinical portions begin soon.

SOM WELCOMES NEW FACULTY MEMBER
Ercument Dirice, Ph.D., assistant professor of pharmacology, was recently recruited from
the prestigious Joslin Diabetes Research Center at Harvard University. His exciting research
is focused on new ways to halt Type I diabetes and even allow new regeneration of insulin
producing cells. This research could help people with Type I diabetes all over the world.
Dr. Dirice recently published two groundbreaking studies in high-impact journals:


Human duct cells contribute to β cell compensation in insulin resistance.



Boosting to Amplify Signal with Isobaric Labeling (BASIL) Strategy for Comprehensive Quantitative
Phosphoproteomic Characterization of Small Populations of Cells.

“It is very exciting to observe that inducing beta cell replication in a timely manner resulted in a reshaped
immune profile which specifically protects beta cells being targeted,” said Dr. Dirice.
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RESEARCH SPOTLIGHT

NYMC RESEARCHERS AIM TO TRANSFORM
TREATMENT OF BABESIOSIS
New York Medical College (NYMC) researchers have made great strides in the fight
against the tick-borne illnesses. The latest is a groundbreaking study, Could the Drug
Tafenoquine Revolutionize Treatment of Babesia Microti Infection by Dana G. Mordue,
Ph.D., associate professor of microbiology and immunology, and Gary P. Wormser,
M.D., professor of medicine, microbiology and immunology, and pharmacology, and
vice chair of medicine for research and development, published in The Journal of
Infectious Diseases. The pair discovered that the drug Tafenoquine, which recently
gained FDA approval to treat some species of Plasmodium, the parasite that causes
Malaria, may also be extremely successful for the treatment of Babesiosis.
Read the full article on the treatment of Babesiosis.

RESEARCH INFORMATION UPDATES/NIH LINKS
SEE WEEKLY NIH ANNOUNCEMENTS:
Learn more about weekly NIH funding opportunities here
TRAINING EARLY STAGE PHYSICIANS & SURGEONS:
Read about NIH grants here
NATIONAL INSTITUTE ON AGING
Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed)
(RFA-AG-20-039)
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GRANTS AND DEPARTMENT RESEARCH
G RANTS C ORNER
Mitchell Cairo, M.D., professor of pediatrics, pathology, microbiology and immunology, medicine and cell biology
and anatomy, Department of Pediatrics, (PI) has been awarded a $320,000 grant sponsored by Miltenyi Biotec,
Inc., for, “A Pilot Study in the Treatment of Refractory Adenovirus (ADV) Infections with Related Donor ADV
Specific Cytotoxins T-Cells in Children, Adolescents and Young Adult Recipients.”
Michael Goligorsky, M.D., Ph.D., professor of medicine, pharmacology, physiology and Dong Sun, M.D., Ph.D.,
professor of physiology, co-PIs, were awarded a prestigious NIH grant (July 2019 ) for, "Glycocalyx repair in sepsis
using liposomal carriers of preassembled glycocalyx.” This study consists of evaluating the efficacy of the recently
invented by the PIs liposomal nanocarriers of preassembled glycocalyx in curtailing the cardiovascular and renal
complications of sepsis.
Marina K. Holz, Ph.D., dean of the Graduate School of Basic Medical Sciences and a prominent breast cancer
researcher, was awarded a prestigious NIH Outstanding Investigator grant for $2,050,000 to further her study of
the Estrogen-mTOR Relationship. In many cancers, mTOR (a molecule present in all cells whose function is to
regulate how cells grow) is turned on more than it should be, causing abnormal cell growth and forming tumors.
This project will study how this happens and what we can do to interfere with the estrogen-mTOR relationship to
stop tumor cells from growing.
Sudhir Jain, Ph.D., assistant professor of pathology, Department of Pathology, PI, was awarded a presitgious NIH
grant for $1.6M, over the course of four years, to support the project, “Hypertension and Inflammation: novel
insights from human AT1Receptor variants.”
John Phillips, M.D., professor of urology, Department of Urology, and Dazhong Xu, Ph.D., assistant professor of
pathology, Department of Pathology, (co-PIs) were bestowed with the Empire Clinical Research Investigator
Program Award (ECRIP), in the amount of $574,000, over the course of two years, from the NY State Department
of Health to support the project, “Nanoparticle Therapy Center: Multidisciplinary Approach to Develop Therapies
for Organ Preservation in Bladder Cancer Using Nano-Carrier Delivered Chemotherapy.” Bladder cancer is the
fifth most common malignancy in New Yorkers and the most expensive cancer to treat in Medicare beneficiaries.
Their lab has begun work in collaboration with Johns Hopkins and New York University to test the efficicacy and
pharmacokinetics of nanoparticle delivered drug therapy.
Julian Stewart, M.D., Ph.D., professor of pediatrics, Department of Physiology and Medicine, and senior
pediatric cardiologist, continues his on-going success as PI, with a $610,000 grant awarded this June, from the
Department of Health and Human Services National Institutes of Health, National Heart, Lung and Blood
Institute. This grant will support the project, “Cardiovagal baroreflex deficits impar neurovascular coupling and
cognition in Postural Tachycardia Syndrome.”
Gary Wormser, M.D., professor of medicine, microbiology and immunology, pharmacology, and vice chair of
medicine for research and development, in collaboration with Dana Mordue, Ph.D., associate professor of
microbiology and immunology, (co-PIs) were awareded a prestigious NIH grant of $451,000 for the project,
“Tafenoquine as a Potential Revolutionary Treatment of Babesiosis.”
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ANNUAL STUDENT RESEARCH EVENT
There has been exciting research conducted by our students and this was highlighted at the 23rd Annual
Medical Student Research Forum (MSRF). There were 60 presenters this year --- a record number. The
MSRF showcases SOM student research, much of which is later published in peer-reviewed publications or
presented at national or international conferences. View more photos here.

STUDENTS PUBLISH IN MEDICAL JOURNALS

It's an impressive feat for anyone to get published in an academic medical journal, even more so to be published
as a student --- yet, these impressive New York Medical College (NYMC) students recently achieved just that.
In October of 2018, Brian Tung (left) School of Medicine (SOM) Class of 2022, authored "Krüppel-like factor
9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells," which
was published in the peer-reviewed medical journal, BMC Cancer. Adam M. Karp (right) SOM Class of 2019,
in collaboration with Mill Etienne M.D. '02, M.P.H., associate dean for student affairs and clinical assistant
professor of neurology, and NYMC alum Nathan Carberry, M.D. '17, co-authored, "Healing through SelfExpression: The Role of Art Therapy in Medicine," which was published in the Journal of Health and Human
Experience. Read the full article on the student publications.

STUDENT RESEARCH LINK TO OUR WEBSITE
Read more about NYMC SOM student research here.
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THE M.D. RESEARCH CONCENTRATION TRACK
Facilitating research for our medical students is one of our top priorities.
This summer, I have partnered with Mary Petzke, Ph.D., assistant dean for
medical student research and, assistant professor of microbiology and
immunology, to increase the number of stipends to support medical student
research. Next year, we plan to further increase the stipends and include
stipends to support the mentors.
The M.D. Research Concentration, is one of the five tracks available as
options to SOM students under the Areas of Concentration program. The
Areas of Concentration were established four years ago, and students in the Class of 2019 were the first to
complete the program; 29 students graduated with Distinction in Research. The M.D. Research Concentration is
not a requirement for all students, but it encapsulates NYMC’s renewed focus on promoting SOM student
engagement in scientific inquiry.
The overarching objective of the M.D. Research Concentration is to prepare students to be leaders in the
field of biomedical research. This area of concentration offers students a unique opportunity to participate in
the process of data acquisition and evaluation that drives the evolution of medical knowledge and provides the
foundation for the development of new diagnostic and therapeutic modalities. Students will develop the skills to
critically evaluate the primary literature, develop and test a hypothesis, interpret results, and effectively
communicate scientific data.
There are five required elements to the M.D. Research Concentration:
1)

Foundation course

2)

Student-organized seminar series

3)

Faculty-mentored independent research project

4)

Presentation of results at the Medical Student Research Forum

5)

Generation of a peer-reviewed scholarly product
(published manuscript or abstract)
New York Medical College
40 Sunshine Cottage Road,
Valhalla, New York 10595
914-594-4000
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